World's first 'Made in India' nasal vaccine for Covid launched

Updated : Jan 28, 2023 15:52
|
PTI

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday.

The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.

According to a statement issued by Bharat Biotech earlier, 'iNCOVACC' is priced at Rs 800 for private markets and at Rs 325 for supplies to the government of India and state governments iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candidate was evaluated in phase I, II and III clinical trials with successful results, the Hyderabad-based vaccine maker had said.

Clinical trials were conducted to evaluate iNCOVACC as a primary dose schedule and as a heterologous booster dose for subjects who have previously received two doses of either Covishield or Covaxin.

(PTI)

covid

Recommended For You

editorji | India

Blue Drum Murder Case: Saurabh Rajput’s Mother Welcomes Death Sentence for Muskan, Sahil

editorji | India

Owaisi Moves Supreme Court Against SIR, Files Review Petition

editorji | India

Delhi Police Traces Protest Rumour-Spreading Social Media Handle to Pakistan

editorji | India

Cabinet approves Productivity Linked Bonus (PLB) for 78 days to Railway Employees

editorji | India

Rahul Gandhi Asks Youth to Document Police Brutality, Preserve Evidence of 'Unlawful Detention'